Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227.
Resource Type
Article
Authors
Brahmer, Julie R. ; Lee, Jong-Seok ; Ciuleanu, Tudor-Eliade ; Bernabe Caro, Reyes ; Nishio, Makoto ; Urban, Laszlo ; Audigier-Valette, Clarisse ; Lupinacci, Lorena ; Sangha, Randeep ; Pluzanski, Adam ; Burgers, Jacobus ; Mahave, Mauricio ; Ahmed, Samreen ; Schoenfeld, Adam J. ; Paz-Ares, Luis G. ; Reck, Martin ; Borghaei, Hossein ; O'Byrne, Kenneth J. ; Gupta, Ravi G. ; Bushong, Judith
Source
Journal of Clinical Oncology; 2/20/2023, Vol. 41 Issue 6, p1200-1212, 13p
Subject
Language
ISSN
0732183X